Evidence map›Paper›PMID 42427590›Full record

ArticlebioRxiv : the preprint server for biology2026

CRISPR activation screens identify core protein-dependent regulation of heparan sulfate sulfation and ligand specificity.

Jack C Moore, Haruki Takeuchi, Caitlien Nguyen, Chin Huang, Digantkumar Chapla, Amrita Basu, Zhangjie Wang, Jian Liu, Kelley W Moremen, Ryan J Weiss

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jack C MooreComplex Carbohydrate Research Center, University of Georgia, Athens, GA.
Haruki TakeuchiComplex Carbohydrate Research Center, University of Georgia, Athens, GA.
Caitlien NguyenComplex Carbohydrate Research Center, University of Georgia, Athens, GA.
Chin HuangComplex Carbohydrate Research Center, University of Georgia, Athens, GA.ORCID 0000-0002-4296-0400
Digantkumar ChaplaComplex Carbohydrate Research Center, University of Georgia, Athens, GA.ORCID 0000-0003-0649-1368
Amrita BasuComplex Carbohydrate Research Center, University of Georgia, Athens, GA.ORCID 0000-0002-9670-9908
Zhangjie WangGlycan Therapeutics Corp, Raleigh, NC.ORCID 0000-0003-4301-953X
Jian LiuDivision of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC.ORCID 0000-0001-8552-1400
Kelley W MoremenComplex Carbohydrate Research Center, University of Georgia, Athens, GA.ORCID 0000-0003-1768-582X
Ryan J WeissComplex Carbohydrate Research Center, University of Georgia, Athens, GA.ORCID 0000-0002-4563-6075

Funding

National Glycoscience Resource- CCRC Service and Training - NGlycoR@CCRCR24GM137782 · NIGMS · UNIVERSITY OF GEORGIA · PI Parastoo Azadi · 2020 to 2026
$5.2M
ApoE and Heparan Sulfate Interaction in Alzheimer’s DiseaseR01AG087305 · NIA · RENSSELAER POLYTECHNIC INSTITUTE · PI JIAN LIU, Chunyu Wang · 2024 to 2026
$2.3M
Development of analytical methods for glycosaminoglycans from biological sourcesR44GM142304 · NIGMS · GLYCAN THERAPEUTICS CORPORATION · PI WANG, ZHANGJIE · 2022 to 2023
$2.0M
Investigating the molecular mechanisms of glycosaminoglycan assemblyR35GM150736 · NIGMS · UNIVERSITY OF GEORGIA · PI Ryan Joseph Weiss · 2023 to 2026
$1.5M
Heparan sulfate co-polymerase function and defects in diseaseR01GM154846 · NIGMS · UNIVERSITY OF GEORGIA · PI KELLEY W. MOREMEN · 2024 to 2026
$999k
Illumina NovaSeq 6000 Sequencing SystemS10OD026929 · OD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JEPSEN, KRISTEN LYNN · 2019 to 2019
$600k
Genome-wide Analysis of Anticoagulant Heparin Sulfate for Bioengineering HeparanR21HL167091 · NHLBI · UNIVERSITY OF GEORGIA · PI WEISS, RYAN JOSEPH · 2023 to 2024
$415k
NHLBI NIH HHS R21 HL167091NIA NIH HHS R01 AG087305NIGMS NIH HHS R01 GM154846NIGMS NIH HHS R24 GM137782NIGMS NIH HHS R35 GM150736NIGMS NIH HHS R44 GM142304NIH HHS S10 OD026929
6 · The paper itself

Abstract

Heparan sulfate proteoglycans (HSPGs) are essential cell surface and extracellular matrix glycoconjugates that mediate diverse biological processes through interactions between their heparan sulfate (HS) chains and extracellular ligands. While HS sulfation patterning is known to dictate ligand specificity, how cells control HS assembly to regulate these interactions remains incompletely understood. To systematically identify genetic modifiers of HS-protein interactions, we performed genome-wide CRISPR activation (CRISPRa) screens in HEK293T cells using binding of antithrombin (AT), which selectively recognizes 3-

Indexed as

antithrombinCRISPR activationglycosaminoglycanheparan sulfateproteoglycansyndecan

Identifiers

PMID42427590
PMCPMC13345059

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.